Clinical Consult
In an upcoming Clinical Consult program, thought leaders discuss the critical need for innovative and targeted treatments in managing major depressive disorder (MDD).
In an upcoming Clinical Consult program, thought leaders discuss the critical need for innovative and targeted treatments in managing major depressive disorder (MDD).
Advertisement
Advertisement
Trending on Psychiatric Times
1
NDA Submission: Olanzapine Extended-Release Injectable Suspension for Treatment of Schizophrenia
2
Evenamide for Treatment-Resistant Schizophrenia: Initiation of ENIGMA-TRS 2 Phase 3 Clinical Study
3
FDA Accepts NDA for TRN-257 for Treatment of Narcolepsy and Idiopathic Hypersomnia
4
Data Fails to Show Significant Change in Cognition and Function With Oral Semaglutide for Early Alzheimer Disease
5
